10 Stocks Ray Dalio and Insiders Are Piling Into

Published on November 15, 2022 at 10:00 am by Hamna Asim in Hedge Funds, News

In this article, we discuss 10 stocks Ray Dalio and insiders are piling into. If you want to see more stocks in this selection, check out 5 Stocks Ray Dalio and Insiders Are Piling Into.

Amid a volatile stock market environment, investors are turning towards insiders, billionaires, and famous money managers, in order to replicate their trades or get an idea about the near-term outlook based on their market moves. With Q3 earnings season coming to a close and several mega-cap stocks down meaningfully year-to-date, there is a chance for insiders to extend a vote of confidence by buying up their own company shares.

Investors giving up on stocks because of recession fears amid an uncertain market backdrop may want to reconsider their actions, as insiders at prominent companies like The Boeing Company (NYSE:BA), Costco Wholesale Corporation (NASDAQ:COST), and Booking Holdings Inc. (NASDAQ:BKNG) are going on buying sprees. It is also a good idea to observe billionaire money managers like Ray Dalio, the founder of Bridgewater Associates, which controls a $20 billion stock portfolio as of the end of the third quarter of 2022. In an interview with Barron’s on November 11, Dalio explained his outlook on the economy in the following words:

“When the next big downturn occurs, and the economic pain is greater than the inflation pain, you will see the Fed and other central banks continue money-printing to monetize debt. Then, real rates will go down again, money will become cheaper and more plentiful, and inflation-hedge assets and new innovation/technology-company equities will be most attractive.”

Our Methodology

We used Ray Dalio’s hedge fund Q3 2022 portfolio for this analysis, selecting his largest stock positions which have also had an insider purchase in the last 6 months. We have arranged the list according to the number of hedge fund holders in each firm, tracked by Insider Monkey as of the second quarter of 2022.

Stocks Ray Dalio and Insiders Are Piling Into

10. Sysco Corporation (NYSE:SYY)

Number of Hedge Fund Holders: 32

Sysco Corporation (NYSE:SYY) is an American multinational corporation engaged in distributing food products, kitchen equipment, and tabletop items to restaurants, healthcare and educational facilities, and hospitality businesses. In Q3 2022, Ray Dalio boosted his Sysco Corporation (NYSE:SYY) stake by 1%, holding 1.68 million shares worth about $119 million. On June 21, 2022, an insider also purchased 1,000 units of Sysco Corporation (NYSE:SYY)’s common stock.

On November 1, Sysco Corporation (NYSE:SYY) reported its financial results for the quarter ending September 2022. The company posted a non-GAAP EPS of $0.97, falling short of market estimates by $0.02. The revenue of $19.13 billion climbed 15.9% on a year-over-year basis, beating Wall Street consensus by $430 million.

Argus analyst John Staszak on November 2 raised the price target on Sysco Corporation (NYSE:SYY) to $96 from $92 and kept a Buy rating on the shares. Despite the FQ1 earnings miss, the analyst is optimistic about Sysco Corporation (NYSE:SYY)’s efforts to offset weak food sales to restaurants and hotels by controlling costs and focusing on sales to grocery stores.

According to Insider Monkey’s data, 32 hedge funds were bullish on Sysco Corporation (NYSE:SYY) at the end of Q2 2022, compared to 31 funds in the prior quarter. Nelson Peltz’s Trian Partners held the biggest stake in the company, comprising 8.8 million shares worth about $745 million.

Like The Boeing Company (NYSE:BA), Costco Wholesale Corporation (NASDAQ:COST), and Booking Holdings Inc. (NASDAQ:BKNG), Sysco Corporation (NYSE:SYY) is one of the stocks that insiders are piling into.

9. Starbucks Corporation (NASDAQ:SBUX)

Number of Hedge Fund Holders: 55

Ray Dalio’s Bridgewater Associates owns nearly 3 million shares of Starbucks Corporation (NASDAQ:SBUX) as of the third quarter of 2022, worth $252.5 million and representing 1.27% of the total 13F securities. On September 15, two directors at the coffee giant purchased a total of 64,750 common shares priced at about $92.5 each. In Q3 2022, Starbucks Corporation (NASDAQ:SBUX) reported that comparable store sales increased 7% globally – gaining 11% in the United States and double digits internationally, excluding China.

On November 4, Evercore ISI analyst David Palmer raised the price target on Starbucks Corporation (NASDAQ:SBUX) to $97 from $95 and maintained an Outperform rating on the shares, telling investors that he is “less worried” about FY23 sales and earnings following the company’s Q3 report. He lifted his FY23 EPS estimate to $3.39 from $3.25, which now reflects U.S. same-store sales growth of 8.5%, up from 7.5%.

According to Insider Monkey’s data, 55 hedge funds were long Starbucks Corporation (NASDAQ:SBUX) at the end of Q2 2022, compared to 58 funds in the prior quarter. D E Shaw held a prominent stake in the company, comprising 2.68 million shares worth $204.7 million.

Here is what Polen Global Growth has to say about Starbucks Corporation (NASDAQ:SBUX) in its Q2 2022 investor letter:

“Starbucks, which garners a lower weighting in the Portfolio, had slightly better than average three-month performance. Same Store sales were up double-digits in the U.S. and International exChina, with solid revenue growth across those regions. The company is experiencing cost pressures from wages and input costs though, and China same-store sales were down 23% due to zero-COVID policy restrictions and lockdowns.”

8. CME Group Inc. (NASDAQ:CME)

Number of Hedge Fund Holders: 56

CME Group Inc. (NASDAQ:CME) is an Illinois-based company that operates a financial derivatives exchange for the trading of asset classes such as agricultural products, currencies, energy, interest rates, metals, stock indexes, and cryptocurrencies futures. Ray Dalio owns 318,263 shares of CME Group Inc. (NASDAQ:CME) as of Q3 2022, worth $56.3 million and representing 0.28% of his total 13F portfolio. On November 4, CME Group Inc. (NASDAQ:CME)’s director also purchased close to 49,000 shares priced at $170 per unit.

On November 10, CME Group Inc. (NASDAQ:CME) declared a $1.00 per share quarterly dividend, in line with previous. The dividend is distributable on December 28, to shareholders of the company as of December 9. CME Group Inc. (NASDAQ:CME)’s dividend yield on November 14 came in at 2.27%.

Deutsche Bank analyst Brian Bedell on October 27 raised the price target on CME Group Inc. (NASDAQ:CME) to $202 from $200 and kept a Buy rating on the shares following the “good” Q3 results.

According to Insider Monkey’s data, 56 hedge funds were bullish on CME Group Inc. (NASDAQ:CME) at the end of June 2022, compared to 58 funds in the prior quarter. GuardCap Asset Management held the leading position in the company, comprising 4.2 million shares worth approximately $859 million.

Here is what Baron Durable Advantage Fund has to say about CME Group Inc. (NASDAQ:CME) in its Q1 2022 investor letter:

“CME Group, Inc. (NASDAQ:CME) operates the world’s largest and most diversified derivatives marketplace. Shares rose 4.6%, contributing to results as elevated market volatility and rising interest rates led to higher trading activity on CME’s exchanges. Average daily trading volume increased 19% year-over-year with notable strength in Interest Rates and Equities products. We continue to own the stock due to CME’s strong competitive moats, underpinned by its product breadth and liquidity depth, as well as its sustainable growth characteristics driven by the secular shift from uncleared over-the-counter trading to exchange-traded futures while also benefiting from the rising rate environment.”

7. The Coca-Cola Company (NYSE:KO)

Number of Hedge Fund Holders: 60

Securities filings for the third quarter of 2022 reveal that Ray Dalio’s Bridgewater Associates owns 11.4 million shares of The Coca-Cola Company (NYSE:KO), worth $642.3 million and representing 3.25% of the total portfolio. On October 28, a director at The Coca-Cola Company (NYSE:KO) also purchased 33,200 shares priced at $60.18 each.

The Coca-Cola Company (NYSE:KO) posted market-beating Q3 results and global unit case volume grew 4%. For the full-year 2022, the company expects to deliver organic revenue growth of 14% to 15%. On October 20, The Coca-Cola Company (NYSE:KO) declared a quarterly dividend of $0.44 per share, in line with previous. The dividend is payable on December 15, to shareholders of record on December 1.

On October 26, UBS analyst Peter Grom raised the price target on The Coca-Cola Company (NYSE:KO) to $68 from $63 and kept a Buy rating on the shares. The company’s Q3 earnings beat was “impressive” as its organic growth largely offset currency headwinds, the analyst told investors in a research note.

According to Insider Monkey’s Q2 data, 60 hedge funds were bullish on The Coca-Cola Company (NYSE:KO), compared to 64 funds in the prior quarter. Warren Buffett’s Berkshire Hathaway held the largest stake in the company, consisting of 400 million shares worth over $25 billion.

Here is what Aristotle Capital specifically said about The Coca-Cola Company (NYSE:KO) in its Q2 2022 investor letter:

“The Coca-Cola Company (NYSE:KO), the global beverage business, was a leading contributor for the period. Coca-Cola continues to benefit from the re-franchising of its bottling operations and realignment of incentives, catalysts we previously identified. These initiatives are demonstrating their strength in an inflationary and supply-chain-challenged environment. Additionally, the company has focused on evolving its customer engagement practices by leveraging digital and social media for targeted campaigns, such as the design and launch of Coke Byte in the metaverse. Lastly, Coca-Cola has furthered its transformation into a total beverage company, as it debuted its new Jack Daniel’s Tennessee Whiskey and Coca-Cola ready-to-drink premixed cocktail. Although uncertainties surrounding cost pressures, lockdowns and geopolitical conflicts remain, we believe Coca-Cola is uniquely positioned to successfully continue its transition toward a total beverage business.”

6. HCA Healthcare, Inc. (NYSE:HCA)

Number of Hedge Fund Holders: 63

HCA Healthcare, Inc. (NYSE:HCA) provides healthcare services in the United States. The company operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, emergency services, and outpatient services. Ray Dalio’s Bridgewater Associates owns 372,040 shares of HCA Healthcare, Inc. (NYSE:HCA) worth $68.3 million as of Q3 2022. Patricia Elcan, a large shareholder of HCA Healthcare, Inc. (NYSE:HCA), purchased 325 shares of the company priced at $198.66 each on July 25.

On October 21, HCA Healthcare, Inc. (NYSE:HCA) declared a $0.56 per share quarterly dividend, in line with previous. The dividend is payable on December 28, to shareholders of the company as of December 14.

Citi analyst Jason Cassorla on October 26 raised the price target on HCA Healthcare, Inc. (NYSE:HCA) to $251 from $240 and kept a Buy rating on the shares following the Q3 results.

According to Insider Monkey’s Q2 data, 63 hedge funds were long HCA Healthcare, Inc. (NYSE:HCA), compared to 62 funds in the prior quarter. Harris Associates is the largest stakeholder of the company, with 7.75 million shares worth $1.30 billion.

In addition to The Boeing Company (NYSE:BA), Costco Wholesale Corporation (NASDAQ:COST), and Booking Holdings Inc. (NASDAQ:BKNG), HCA Healthcare, Inc. (NYSE:HCA) is backed by elite hedge funds and insiders alike.

Here is what Diamond Hill Capital Management specifically said about HCA Healthcare, Inc. (NYSE:HCA) in its Q2 2022 investor letter:

“HCA Healthcare, Inc. (NYSE:HCA) is a best-in-class operator of acute care hospitals and other health care facilities, including outpatient surgery centers. It has a strong market presence in highly attractive geographies with growing populations and low unemployment, such as Texas and Florida, which leads to a favorable payor mix. We are further attracted to its strong management team that has a stellar track record of deploying capital, and the founding family continues to own almost a quarter of the business. We initiated a position after HCA reported Q1 earnings — it reduced full year guidance due to increased labor costs and lower-than-expected acuity among COVID admissions, dampening near-term investor sentiment.”

Click to continue reading and see 5 Stocks Ray Dalio and Insiders Are Piling Into.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on November 14, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up